Raptor Pharm (RPTP) Misses Q4 EPS by 3c

Raptor Pharm (NASDAQ: RPTP) reported Q4 EPS of ($0.26), $0.03 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $0 versus the consensus estimate of $250 thousand.

For earnings history and earnings-related data on Raptor Pharm (RPTP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
• Wendy's U.S. president to resign, company to create COO role